Emicizumab-kxwh Subcutaneous and Novo-Methacin Suppositories
Determining the interaction of Emicizumab-kxwh Subcutaneous and Novo-Methacin Suppositories and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emicizumab
Brand name: Hemlibra, Hemlibra 105 mg/07 mL, Hemlibra 60 mg/04 mL
Synonyms: Emicizumab
Generic Name: indomethacin
Brand name: Indocin, Indocin SR, Tivorbex
Synonyms: Indomethacin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Emicizumab-kxwh Subcutaneous-Novo-Peridol
- Emicizumab-kxwh Subcutaneous-Novo-Trimel
- Emicizumab-kxwh Subcutaneous-Novocain
- Emicizumab-kxwh Subcutaneous-Novoeight
- Emicizumab-kxwh Subcutaneous-Novoeight recombinant
- Emicizumab-kxwh Subcutaneous-Novolin 70/30
- Novo-Methacin Suppositories-Emla
- Novo-Methacin Suppositories-Emla Topical
- Novo-Methacin Suppositories-Emo-Cort Scalp Solution Topical application
- Novo-Methacin Suppositories-Emo-Cort Topical application
- Novo-Methacin Suppositories-Emoquette
- Novo-Methacin Suppositories-Empagliflozin